...
【24h】

Synthesis and antitumor activity of new pyrido2,3-dpyrimidine derivatives

机译:新型吡啶并2,3-d嘧啶衍生物的合成及抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

New series of pyrido2,3-dpyrimidines such as; 5-(4-aryl-5-sulfanyl-4H-l,2,4triazol-3-yl) lH,3H,8H-pyr-ido2,3-dpyrirnidine~2,4,7-triones 6,7; S-3-(2,4,7-trioxo-l ,2, 3,4,7,8-hexahydropyrido2,3-dpyrimidin-5-yl)-4-(4-substituted phenyl)-4H-l ,2,4triazol-5-yl-2-(4-phenylpi-perazin-l-yl)ethanethioates 10, 11; 2,4,7-trioxo-N'-(4-substituted piperazin-l-yl)acetyl-l,2,3,4,7,8-hexahydro-pyrido2,3-dpyrimidine-5-carbohydrazides 13-16 and 7V-arylidene-2,4,7-trioxo-l,2,3,4,7,8-hexahydropyrido2,3-dpyrimidine-5-carbohydrazides 17-19 was synthesized through the reaction of the key intermediate 2,4, 7-trioxo-l,2,3,4,7,8-hexahydropyrido2,3-dpyrimidine-5-carbohydrazide 3 with different reagents. The structures of the newly synthesized compounds were elucidated through microanalysis, IR, ~1H NMR, 13C NMR, and mass spec-troscopy. These compounds have been subjected to in vitro antitumor evaluation by bleomycin-dependant DNA damage assay. The most active antitumor compound 6 was selected for further in vivo evaluation of antineoplastic activity against Ehrlich ascites carcinoma in mice. It was observed that our target compound has a potent antitumor activity.
机译:新系列的吡啶并[2,3-d]嘧啶,如;5-(4-芳基-5-硫基-4H-[l,2,4]三唑-3-基)lH,3H,8H-吡喃并[2,3-d]吡啶~2,4,7-三酮 6,7;S-[3-(2,4,7-三氧代-l,2,3,4,7,8-六氢吡啶并[2,3-d]嘧啶-5-基)-4-(4-取代苯基)-4H-[l,2,4]三唑-5-基]-2-(4-苯基吡啶-啌嗪-l-基)硫代乙酯 10, 11;2,4,7-三氧代-N'-[(4-取代哌嗪-l-基)乙酰基]-l,2,3,4,7,8-六氢吡啶并[2,3-d]嘧啶-5-甲酰肼13-16和7V-亚基-2,4,7-三氧代-l,2,3,4,7,8-六氢吡啶并[2,3-d]嘧啶-5-甲酰肼17-19由关键中间体2,4,7,7,8-六氢吡啶并[2,3-d]嘧啶-5-甲酰肼3与不同试剂反应合成。通过显微分析、红外光谱、~1H NMR、13C NMR和质谱分析阐明了新合成化合物的结构。这些化合物已通过博来霉素依赖性 DNA 损伤测定进行体外抗肿瘤评估。选择最活跃的抗肿瘤化合物 6 用于进一步体内评估小鼠对埃利希腹水癌的抗肿瘤活性。据观察,我们的靶化合物具有有效的抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号